Cellid, Co., Ltd. (299660.KQ)

KRW 5500.0

(-7.25%)

Long Term Debt Summary of Cellid, Co., Ltd.

Cellid, Co., Ltd.'s latest annual long term debt in 2023 was 6.48 Billion KRW , up 73189.95% from previous year.
Cellid, Co., Ltd.'s latest quarterly long term debt in 2024 Q2 was 9.43 Billion KRW , up 22.75% from previous quarter.
Cellid, Co., Ltd. reported annual long term debt of 8.85 Million KRW in 2022, down -99.94% from previous year.
Cellid, Co., Ltd. reported annual long term debt of 15.7 Billion KRW in 2021, up 28748.51% from previous year.
Cellid, Co., Ltd. reported quarterly long term debt of 9.43 Billion KRW for 2024 Q2, up 22.75% from previous quarter.
Cellid, Co., Ltd. reported quarterly long term debt of - KRW for 2023 Q2, down -100.0% from previous quarter.

Annual Long Term Debt Chart of Cellid, Co., Ltd. (2023 - 2015)

Historical Annual Long Term Debt of Cellid, Co., Ltd. (2023 - 2015)

Year	Long Term Debt	Long Term Debt Growth
2023	6.48 Billion KRW	73189.95%
2022	8.85 Million KRW	-99.94%
2021	15.7 Billion KRW	28748.51%
2020	54.43 Million KRW	7.69%
2019	50.54 Million KRW	0.0%
2018	- KRW	0.0%
2017	- KRW	0.0%
2016	- KRW	0.0%
2015	- KRW	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q1	7.68 Billion KRW	18.52%
2024 Q2	9.43 Billion KRW	22.75%
2023 Q2	- KRW	-100.0%
2023 Q1	4.51 Million KRW	-49.04%
2023 Q4	6.48 Billion KRW	26.35%
2023 Q3	5.13 Billion KRW	0.0%
2023 FY	6.48 Billion KRW	73189.95%
2022 Q4	8.85 Million KRW	-32.06%
2022 Q2	11.36 Million KRW	-99.93%
2022 FY	8.85 Million KRW	-99.94%
2022 Q1	15.88 Billion KRW	1.13%
2022 Q3	13.02 Million KRW	14.66%
2021 Q2	11.73 Billion KRW	2.57%
2021 FY	15.7 Billion KRW	28748.51%
2021 Q3	12.04 Billion KRW	2.57%
2021 Q4	15.7 Billion KRW	30.42%
2021 Q1	11.44 Billion KRW	20926.47%
2020 Q1	46.51 Million KRW	-7.98%
2020 Q2	68.38 Million KRW	47.04%
2020 FY	54.43 Million KRW	7.69%
2020 Q3	61.53 Million KRW	-10.02%
2020 Q4	54.43 Million KRW	-11.54%
2019 FY	50.54 Million KRW	0.0%
2019 Q3	37.43 Million KRW	-9.57%
2019 Q1	- KRW	0.0%
2019 Q4	50.54 Million KRW	35.01%
2019 Q2	41.39 Million KRW	0.0%
2018 Q1	- KRW	0.0%
2018 FY	- KRW	0.0%
2018 Q2	- KRW	0.0%
2018 Q4	- KRW	0.0%
2017 FY	- KRW	0.0%
2017 Q1	- KRW	0.0%
2017 Q4	- KRW	0.0%
2016 FY	- KRW	0.0%
2015 FY	- KRW	0.0%

Peer Long Term Debt Comparison of Cellid, Co., Ltd.

Name	Long Term Debt	Long Term Debt Difference
Sam Chun Dang Pharm. Co., Ltd	16 Billion KRW	59.455%
Hyundai Bioscience Co., Ltd.	32.43 Million KRW	-19902.561%
ST Pharm Co.,Ltd.	159.68 Billion KRW	95.938%
ABL Bio Inc.	43 Billion KRW	84.913%